
浏览全部资源
扫码关注微信
纸质出版日期:2013
移动端阅览
袁艺, 赵波, 陈劲秋. 解郁化浊汤防治2型糖尿病前期56例[J]. 中国实验方剂学杂志, 2013,19(24):314-317.
YUAN Yi, ZHAO Bo, CHEN Jin-qiu. Therapeutic Effect of Jieyu Huazhuo Decoction on Treating 46 Cases of Type 2 Prediabetes[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(24): 314-317.
袁艺, 赵波, 陈劲秋. 解郁化浊汤防治2型糖尿病前期56例[J]. 中国实验方剂学杂志, 2013,19(24):314-317. DOI: 10.11653/syfj2013240314.
YUAN Yi, ZHAO Bo, CHEN Jin-qiu. Therapeutic Effect of Jieyu Huazhuo Decoction on Treating 46 Cases of Type 2 Prediabetes[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(24): 314-317. DOI: 10.11653/syfj2013240314.
目的: 探讨解郁化浊汤对2型糖尿病前期(气滞痰阻证)的临床疗效。方法: 将111例患者随机按数字法分为对照组55例和观察组56例。两组均采用基础干预,包括控制饮食、健康教育、运动等一般治疗,观察组加服解郁化浊汤,1剂/d, 疗程均为12周。检测治疗前后空腹血糖(FBG)、餐后2 h血糖(2 hPBG)、空腹胰岛素(FINS)、餐后2 h胰岛素 (2 hINS)糖化血红蛋白(HbA1c)、血脂(TC总胆固醇、TG甘油三酯、HDL-C高密度脂蛋白、LDL-C低密度脂蛋白),测量患者体重、腰围和臀围及记录中医证候积分,并随访患者的转归。结果: 治疗后观察组15例(26.78%)糖代谢正常,优于对照组的6例(10.91%)(P<0.05),观察组为7例(12.5%)转为T2 DM,少于对照组的17例(30.91%)(P<0.05);对照组治疗后FBG,2 hPBG,HbA1c,FINS,2 hINS均呈上升趋势,观察组以上指标则明显下降(P<0.05,P<0.01),观察组FBG,2 hPBG,HbA1c、FINS,2 h INS均低于对照组(P<0.05,P<0.01);观察组BMI、体重、腰围及WHR改善均明显优于对照组(P<0.05);观察组TG,HDL-C均较治疗前下降(P<0.05);观察组形体肥胖、脘腹胀闷、心烦、大便干结及口苦等症状评分均低于对照组(P<0.01)。结论: 在基础干预的基础上,解郁化浊汤能改善胰岛素抵抗,调节糖脂代谢,改善患者临床症状、体征,对防止糖尿病前期患者转化为T2 DM有一定的疗效。
Objective: To discuss the clinical efficacy of Jieyu Huazhuo decoction on treating type 2 prediabetes (qi stagnation and phlegm obstruction type). Method: One hundred and eleven patients with chronic pyelonephritis were randomly divided into observation group (n=56) and control group (n=55). Patients in the two groups were both treated with basis interventions
including diet
health
education and sports. Jieyu Huazhuo decoction was used in the observation group (one dose per day
12 weeks as one cycle). Fasting blood glucose (FBG)
2 h postprandial blood glucose (2 h PBG)
fasting insulin (FINS)
2 h postprandial insulin (2 h INS)
glycosylated hemoglobin (HbA1c) and blood lipids total cholesterol (TC)
riglycerides (TG)
high density lipoprotein (HDL-C)
low densith lipoprotein (LDL-C) were tested before and after treatment
the patient's body weight
waist and hip and TCM syndrome score were measured. The patient's outcome was follow-up. Result: After treatment
15 cases in observation group (26.78%) have normal glucose metabolism
better than the control group (6 cases
10.91%) (P<0.05). 7 cases in the observation group (12.5%) was converted to T2 DM
lower than the control group (17 cases
30.91%) (P<0.05);After treatment FBG
2 h PBG
HbA1c
FINS
2 h INS of the patients in control group showed an upward trend
and the observation group index decreased significantly (P<0.05
P<0.01). FBG
2 hPBG
HbA1c
FINS
2 hINS of observation group were lower than the control group (P<0.05
P<0.01);BMI
weight
waist circumference and improment of WHR in observation group were significantly better than the control group (P<0.05);TG
HDL-C of observation group were decreased after treatment (P<0.05);Scores of body fat
abdominal distension
nausea
irritability
dry stool and mouth waiting symptom of observation group were lower than the control group (P<0.01). Conclusion: Based on the basis interventions
regulate glucose and lipid metabolism
improve clinical symptoms and signs
to prevent prediabetes into T2 DM have a certain effect.
0
浏览量
4
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621